The reduction in the capacity of the IL-6ST/gp130 receptor to activate STAT1 and STAT3 in our heterozygous GP130∆STAT/+ mice demonstrates that IL-6ST/gp130 receptor signalling is required for the maintenance of intestinal barrier function during colitis. This evidence concerns the gene STAT3 and colitis.